Golden Triangle Ventures Announces the Launch of Sales on Its Le Pragma CBD Product Line
August 08, 2023 08:30 ET
|
Golden Triangle Ventures, Inc.
LAS VEGAS, Aug. 08, 2023 (GLOBE NEWSWIRE) -- via IBN -- Golden Triangle Ventures, Inc. (OTC PINK: GTVH) (“GTV” or the “Company”) announces the launch of sales and provides an update on the progress...
Incannex Healthcare June 2023 Quarterly Activities Report and Appendix 4C Cash Flow Statement
July 28, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 28, 2023 (GLOBE NEWSWIRE) -- Clinical stage pharmaceutical development company, Incannex Healthcare Limited (ASX: IHL) (NASDAQ: IXHL), (‘Incannex’ or the ‘Company’), is...
Symple Seeds Opens Massive Fulfillment Center in South Florida to Service US Customers
July 26, 2023 15:13 ET
|
Symple Seeds
MIAMI, July 26, 2023 (GLOBE NEWSWIRE) -- Symple Seeds, a cannabis seed shipping and logistics company with over a decade in the industry, is opening a new fulfillment center in South Florida. Now,...
Incannex Completes Positive Pre-IND Meeting with US FDA on IHL-675A for Treatment of Rheumatoid Arthritis
July 26, 2023 07:30 ET
|
Incannex Healthcare
MELBOURNE, Australia, July 26, 2023 (GLOBE NEWSWIRE) -- Incannex Healthcare Limited (Nasdaq: IXHL) (ASX: IHL), (‘Incannex’ or the ‘Company’) a clinical-stage pharmaceutical company developing unique...
SciSparc to Commence Its Clinical Trial with SCI-210 in Children with Autism Spectrum Disorder
July 14, 2023 07:55 ET
|
SciSparc Ltd
“We hope the outcome of this trial will enable the Company to procced with commercialization process for SCI-210 in Israel" TEL AVIV, Israel, July 14, 2023 (GLOBE NEWSWIRE) -- SciSparc Ltd....
Incannex Receives HREC Approval for Phase 2 Clinical Trial Assessing IHL-675A for use in Treatment of Pain and Function in Rheumatoid Arthritis
July 13, 2023 08:00 ET
|
Incannex Healthcare
Highlights: Incannex has received approval from HREC for the lead site, Emeritus Research, Camberwell, VIC for the Phase 2, Blinded, Placebo Controlled Clinical Trial to Determine the Effect on Pain...
BYND Cannasoft Announces Successful Completion of Laboratory Testing Phase for EZ-G Device Optimization
July 10, 2023 08:30 ET
|
BYND Cannasoft Enterprises, Inc.
ASHKELON, Israel and VANCOUVER, British Columbia, July 10, 2023 (GLOBE NEWSWIRE) -- BYND Cannasoft Enterprises Inc. (Nasdaq: BCAN) (CSE: BYND) (“BYND Cannasoft” or the “Company”) announced today the...
Rocky Mountain High Brands Business Growth Prompts Relocation
July 06, 2023 09:00 ET
|
Rocky Mountain High Brands, Inc.
PLANO, Texas, July 06, 2023 (GLOBE NEWSWIRE) -- Rocky Mountain High Brands, Inc. (OTC: RMHB) today announced that it has relocated its corporate headquarters and its production subsidiary, Rocky...
Walter Lynch, Retired CEO of American Water, Joins the Board of Qredible
June 15, 2023 09:00 ET
|
Qredible
CHERRY HILL, N.J., June 15, 2023 (GLOBE NEWSWIRE) -- Walter Lynch is a water industry veteran, having led the water and waste sectors through seasons of transformation as CEO of American Water, the...
SOMAÍ Pharmaceuticals Signs Supply Contract with Cosma Poland
June 12, 2023 01:00 ET
|
SOMAÍ Pharmaceuticals
LISBON, Portugal, June 12, 2023 (GLOBE NEWSWIRE) -- SOMAÍ Pharmaceuticals Unipessoal LDA (“SOMAÍ”) has entered into a two-year supply agreement with a well-respected Polish distributor Cosma...